Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease Diagnosis
Recruiting
Observational Study
Alzheimer's Disease Diagnosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 55 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- Chinese University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The most significant impact of this project is to propose for the first time a novel generative adversarial network (GAN), as one kind of deep learning architecture, to automatically generate synthetic PET images reflecting tau deposition, from brain DTI images. If successful, this framework will become the most state-of-the-art approach to simulate the stereotypical pattern of intracerebral tau a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* With the age of 55 years and above
* With brain MRI taken within ±6 months from the date of clinically confirmed diagnosis of AD, MCI or normal cognition.
Exclusion Criteria:
* AD with mixed dementia
* Non-AD dementia
* History of severe traumatic brain injury, severe depres…
Contacts
No contact information available.